165 related articles for article (PubMed ID: 23934027)
1. Immune regulation by CD52-expressing CD4 T cells.
Toh BH; Kyaw T; Tipping P; Bobik A
Cell Mol Immunol; 2013 Sep; 10(5):379-82. PubMed ID: 23934027
[TBL] [Abstract][Full Text] [Related]
2. T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.
Bandala-Sanchez E; Zhang Y; Reinwald S; Dromey JA; Lee BH; Qian J; Böhmer RM; Harrison LC
Nat Immunol; 2013 Jul; 14(7):741-8. PubMed ID: 23685786
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes.
Rowan WC; Hale G; Tite JP; Brett SJ
Int Immunol; 1995 Jan; 7(1):69-77. PubMed ID: 7718516
[TBL] [Abstract][Full Text] [Related]
4. Regulation unmasked by activation.
Clark M; Cooke A
Nat Immunol; 2013 Jul; 14(7):696-7. PubMed ID: 23778805
[No Abstract] [Full Text] [Related]
5. Siglec-10 expression is up-regulated in activated human CD4
Bandala-Sanchez E; Bediaga NG; Naselli G; Neale AM; Harrison LC
Hum Immunol; 2020; 81(2-3):101-104. PubMed ID: 32046870
[TBL] [Abstract][Full Text] [Related]
6. CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells.
Samten B
Cell Mol Immunol; 2013 Nov; 10(6):456-8. PubMed ID: 24037183
[No Abstract] [Full Text] [Related]
7. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner.
Seggewiss R; Loré K; Greiner E; Magnusson MK; Price DA; Douek DC; Dunbar CE; Wiestner A
Blood; 2005 Mar; 105(6):2473-9. PubMed ID: 15572591
[TBL] [Abstract][Full Text] [Related]
8. Altered proximal T-cell receptor signalling events in mouse CD4+ T cells in the presence of anti-CD4 monoclonal antibodies: evidence for reduced phosphorylation of Zap-70 and LAT.
Pullar CE; Morris PJ; Wood KJ
Scand J Immunol; 2003 Apr; 57(4):333-41. PubMed ID: 12662296
[TBL] [Abstract][Full Text] [Related]
9. CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function.
Bandala-Sanchez E; G Bediaga N; Goddard-Borger ED; Ngui K; Naselli G; Stone NL; Neale AM; Pearce LA; Wardak A; Czabotar P; Haselhorst T; Maggioni A; Hartley-Tassell LA; Adams TE; Harrison LC
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7783-7788. PubMed ID: 29997173
[TBL] [Abstract][Full Text] [Related]
10. CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.
Watanabe T; Masuyama J; Sohma Y; Inazawa H; Horie K; Kojima K; Uemura Y; Aoki Y; Kaga S; Minota S; Tanaka T; Yamaguchi Y; Kobayashi T; Serizawa I
Clin Immunol; 2006 Sep; 120(3):247-59. PubMed ID: 16797237
[TBL] [Abstract][Full Text] [Related]
11. Cloning, characterization, and expression pattern of Atlantic halibut (Hippoglossus hippoglossus L.) CD4-2, Lck, and ZAP-70.
Øvergård AC; Nerland AH; Patel S
Fish Shellfish Immunol; 2010 Dec; 29(6):987-97. PubMed ID: 20728542
[TBL] [Abstract][Full Text] [Related]
12. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
von Kutzleben S; Pryce G; Giovannoni G; Baker D
Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
[TBL] [Abstract][Full Text] [Related]
13. Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment.
Pant AB; Wang Y; Mielcarz DW; Kasper EJ; Telesford KM; Mishra M; Haque A; Channon JY; Kasper LH; Begum-Haque S
J Neuroimmunol; 2017 Feb; 303():22-30. PubMed ID: 28087077
[TBL] [Abstract][Full Text] [Related]
14. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
Van Belle TL; Dooms H; Boonefaes T; Wei XQ; Leclercq G; Grooten J
PLoS One; 2012; 7(9):e45299. PubMed ID: 23028916
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.
Holgate RG; Weldon R; Jones TD; Baker MP
PLoS One; 2015; 10(9):e0138123. PubMed ID: 26372145
[TBL] [Abstract][Full Text] [Related]
16. The CD45 tyrosine phosphatase regulates Campath-1H (CD52)-induced TCR-dependent signal transduction in human T cells.
Hederer RA; Guntermann C; Miller N; Nagy P; Szollosi J; Damjanovich S; Hale G; Alexander DR
Int Immunol; 2000 Apr; 12(4):505-16. PubMed ID: 10744652
[TBL] [Abstract][Full Text] [Related]
17. Subcellular distribution of Lck during CD4 T-cell maturation in the thymic medulla regulates the T-cell activation threshold.
Stephen TL; Wilson BS; Laufer TM
Proc Natl Acad Sci U S A; 2012 May; 109(19):7415-20. PubMed ID: 22529380
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits CD4(+) T cell activation, but augments CD69 expression and TGF-β1-mediated generation of regulatory T cells at late phase.
Kim G; Jang MS; Son YM; Seo MJ; Ji SY; Han SH; Jung ID; Park YM; Jung HJ; Yun CH
PLoS One; 2013; 8(4):e62300. PubMed ID: 23658623
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.
Chen Z; Chen L; Qiao SW; Nagaishi T; Blumberg RS
J Immunol; 2008 May; 180(9):6085-93. PubMed ID: 18424730
[TBL] [Abstract][Full Text] [Related]
20. Analysis of IgG subclass antibodies and expression of T-Cell receptor signaling molecules in anti-CD4 monoclonal antibody treated mice with autoimmune cardiomyopathy.
Wang Z; Liao YH; Yuan J; Zhang JH; Liu ZP; Dong JH
Autoimmunity; 2006 Sep; 39(6):455-60. PubMed ID: 17060024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
